Module 4: Early Detection and Diagnosis of Scleroderma for Primary Care Physicians and Allied Health Professionals

To begin this activity, click Enroll. Once logged in, learners can access educational content, assessments, and evaluations. Learners who successfully complete the activity will be able to print a certificate.

Enroll

Enrollment required to continue.

Step	Status
Educational Materials	✘
Evaluation	✘

Release Date: Thu, 11/16/23

Termination Date: Fri, 11/15/24

Credits: 1

Description: This course will educate primary care physicians, nurse practitioners and nurses of the many signs and symptoms of systemic sclerosis that may result in a referral to a specialist for further care. After completing this activity participants will be able to identify and detect the many signs and symptoms of systemic sclerosis that may result in a referral to a specialist for further care.

Presentation: Etiology and Pathogenesis of Systemic Sclerosis: John Varga, MD (55 mins, 1.0 credits)

Disclosures

All educational planners and presenters have completed disclosures and have no relevant financial relationships to disclose for this activity

Educational Objectives:

Introduce current concepts in scleroderma pathogenesis
Highlight emerging novel opportunities for effective treatment of scleroderma

Target Audience:

This activity is appropriate for House Officers, Medical Students, Nurse Practitioners, Nurses, Other Healthcare Professionals, Physician Assistants, Physicians in the fields of Family Medicine, General Medicine, Primary Care.

Accreditation and Credit Designation:

The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Michigan Medical School designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Additional Info:

Bibliographic Resources

Nadia D. Morgan; Laura K. Hummer, Scleroderma Mimickers, Curr Treatm Opt Rheumatol. 2016 Mar; 2(1): 69-84
Khanna G, Ferguson P. MRI of diabetic cheiroarthropy. AJR Am J Roentgenol. 2007
Hummers LK, Curr Opin Rheumatol. 2014 Nov; 26(6):658-62
Nadia D. Morgan; Laura K. Hummer, Scleroderma Mimickers, Curr Treatm Opt Rheumatol. 2016 Mar; 2(1): 69-84
Morphea and Eosinophilic Fasciitis: An Update. Mertens JS, Seyger MMB, Thurlings RM, Radstake TRDJ, de Jong EMGJ.Mertens JS, et al. Am J Clin Dermatol. 2017
Enzo Errichetti et al, Dermoscopy of Morphea and Cutaneous Lichen Sclersus, Dermatology 2017;233;462-470 DOI: 10.1159/000484947
Marzano AV, Menni S, Parodi A, Borghi A, Fuligni A, Fabbri P, Caputo R Localized scleroderma in adults and children. Clinical and laboratory investigations on 239 cases Eur J Dermatol. 2003 Mar-Apr; 13(2):171-6.
Doyle JA, Ginsburg WW, Eosinophilip fasciitis., Med Clin North Am. 1989 Sep; 73(5):1157-66.

Credits available:

AMA PRA Category 1: 1.00

Participation: 1.00